We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Linzess First Drug to Get FDA Approval for Pediatric Functional Constipation
Linzess First Drug to Get FDA Approval for Pediatric Functional Constipation
Ironwood Pharmaceuticals’ Linzess (linaclotide) is the first drug to receive FDA approval to treat functional constipation in children age six to 17 years with a recommended daily dosage of 72 mcg orally.